HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Pediatric Oncology

Pediatric Oncology
  • Progress in Treating Pediatric Solid Tumors
  • Late Effects of Cancer Treatment in Childhood
  • Emerging Therapies for Childhood Leukemia
  • Genetic Syndromes Predisposing to Pediatric Cancers

Pediatric oncology is a specialized branch of cancer research focused on diagnosing and treating cancers in children. Unlike adult cancers, pediatric cancers often have distinct biological characteristics, making their treatment and prognosis different. Researchers in this field aim to understand the genetic and molecular drivers of childhood cancers, such as leukemia, brain tumors, and neuroblastoma, to develop more effective, less toxic therapies. Advances in pediatric oncology have led to significant improvements in survival rates, but challenges remain in reducing long-term side effects from treatments. Ongoing studies emphasize precision medicine, genetic therapies, and novel drug development to provide better outcomes for young patients. Collaborative efforts between research institutes, healthcare providers, and families play a crucial role in advancing pediatric oncology and ensuring a brighter future for children battling cancer.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp